Methodology

All entries for: Eloxx Pharmaceuticals

August 19, 2026

Eloxx Pharmaceuticals

Orphan Drug Designation

Arlington, MA
1-50 employees

treatment of autosomal dominant polycystic kidney disease

Disease Area: Rare Diseases
Source
March 17, 2026

Eloxx Pharmaceuticals

Neutral Outlook

Arlington, MA
1-50 employees

The impact of the IRA on us and the pharmaceutical industry cannot yet be fully determined, but is likely to be significant.

Disease Area: Rare Diseases
Drug Type: Small Molecule
Source
Source
Scroll to Top